Circulating Tumor DNA Methylation Signatures for Early-Stage Colorectal Cancer Detection and Tissue-of-Origin Classification: Validation in a Prospective 2,840-Patient Cohort
This study investigates circulating tumor DNA methylation signature panel for early-stage (I-II) colorectal cancer detection and tissue-of-origin confirmation in a prospective validation cohort within the context of oncology and liquid biopsy diagnostics, an area of growing scientific importance given its implications...